{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:53:47Z","timestamp":1786550027979,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1038\/ajg.2016.44","type":"journal-article","created":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T08:21:46Z","timestamp":1456820506000},"page":"671-676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Using an Electronic Medical Records Database to Identify Non-Traditional Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease"],"prefix":"10.14309","volume":"111","author":[{"given":"Kathleen E","family":"Corey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Kartoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond T","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley Y","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20210210","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"R2-23-20210210","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"R3-23-20210210","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/hep.23314","article-title":"Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.","volume":"51","author":"Soderberg","year":"2010","journal-title":"Hepatology"},{"key":"R4-23-20210210","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.24491","article-title":"The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.","volume":"54","author":"Bhala","year":"2011","journal-title":"Hepatology"},{"key":"R5-23-20210210","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","article-title":"Long-term follow-up of patients with nonalcoholic fatty liver.","volume":"7","author":"Rafiq","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R6-23-20210210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"St, Sauver J et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study.","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"R7-23-20210210","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1148\/radiol.14140933","article-title":"High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial.","volume":"274","author":"Puchner","year":"2015","journal-title":"Radiology"},{"key":"R8-23-20210210","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cgh.2011.12.039","article-title":"Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population.","volume":"10","author":"Stepanova","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R9-23-20210210","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2337\/dc07-0349","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients.","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"R10-23-20210210","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1478-3231.2011.02753.x","article-title":"The Framingham risk score and heart disease in nonalcoholic fatty liver disease.","volume":"32","author":"Treeprasertsuk","year":"2012","journal-title":"Liver Int"},{"key":"R11-23-20210210","first-page":"655","article-title":"Cardiovascular disease in cirrhosisa point-prevalence study in relation to glucose tolerance.","volume":"94","author":"Marchesini","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R12-23-20210210","first-page":"G459","article-title":"Enhanced endothelium-dependent vasodilation in patients with cirrhosis.","volume":"268","author":"Albillos","year":"1995","journal-title":"Am J Physiol"},{"key":"R13-23-20210210","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(00)80422-5","article-title":"Complications of cirrhosis. I. Portal hypertension.","volume":"32","author":"Bosch","year":"2000","journal-title":"J Hepatol"},{"key":"R14-23-20210210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1464-5491.2007.02025.x","article-title":"Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens.","volume":"24","author":"Targher","year":"2007","journal-title":"Diabet Med"},{"key":"R16-23-20210210","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"R17-23-20210210","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.21563","article-title":"The model for end-stage liver disease (MELD).","volume":"45","author":"Kamath","year":"2007","journal-title":"Hepatology"},{"key":"R18-23-20210210","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease.","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"R19-23-20210210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis.","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology"},{"key":"R20-23-20210210","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cgh.2009.12.015","article-title":"Factors that predict outcome of abdominal operations in patients with advanced cirrhosis.","volume":"8","author":"Telem","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R21-23-20210210","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.cgh.2010.10.035","article-title":"Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease.","volume":"9","author":"Berman","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R22-23-20210210","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jhep.2012.03.037","article-title":"Assessment of risk for non-hepatic surgery in cirrhotic patients.","volume":"57","author":"Bhangui","year":"2012","journal-title":"J Hepatol"},{"key":"R23-23-20210210","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.cgh.2013.03.022","article-title":"An automated model using electronic medical record data identifies patients with cirrhosis at high risk for readmission.","volume":"11","author":"Singal","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R24-23-20210210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2013.11.026","article-title":"A new comorbidity model for predicting mortality in patients with cirrhosis: does it work?","volume":"146","author":"Younossi","year":"2014","journal-title":"Gastroenterology"},{"key":"R25-23-20210210","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/lt.24063","article-title":"Serum sodium and survival benefit of liver transplantation.","volume":"21","author":"Sharma","year":"2015","journal-title":"Liver Transplant"},{"key":"R26-23-20210210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.20517","article-title":"Serum sodium predicts mortality in patients listed for liver transplantation.","volume":"41","author":"Biggins","year":"2005","journal-title":"Hepatology"},{"key":"R27-23-20210210","first-page":"49","article-title":"Markers of activated inflammatory cells correlate with severity of liver damage in children with nonalcoholic fatty liver disease.","volume":"30","author":"De Vito","year":"2012","journal-title":"Int J Mol Med"},{"key":"R28-23-20210210","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.atherosclerosis.2009.10.011","article-title":"Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease.","volume":"209","author":"Sookoian","year":"2010","journal-title":"Atherosclerosis"},{"key":"R29-23-20210210","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jn\/138.8.1452","article-title":"Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake.","volume":"138","author":"Thuy","year":"2008","journal-title":"J Nutr"},{"key":"R30-23-20210210","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/oby.2008.64","article-title":"NASH predicts plasma inflammatory biomarkers independently of visceral fat in men.","volume":"16","author":"Targher","year":"2008","journal-title":"Obesity"},{"key":"R31-23-20210210","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/j.1538-7836.2011.04429.x","article-title":"Hypercoagulability in cirrhosis: causes and consequences.","volume":"9","author":"Tripodi","year":"2011","journal-title":"J Thromb Haemost"},{"key":"R32-23-20210210","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/s-0029-1222606","article-title":"Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome.","volume":"35","author":"Targher","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"R33-23-20210210","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1161\/01.CIR.69.6.1065","article-title":"Family history of heart attack as an independent predictor of death due to cardiovascular disease.","volume":"69","author":"Barrett-Connor","year":"1984","journal-title":"Circulation"},{"key":"R34-23-20210210","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1001\/jama.291.18.2204","article-title":"et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring.","volume":"291","author":"Lloyd-Jones","year":"2004","journal-title":"J Am Med Assoc"},{"key":"R35-23-20210210","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/euhj.2002.3235","article-title":"Fifteen percent of myocardial infarctions and coronary revascularizations explained by family history unrelated to conventional risk factors. The Reykjavik Cohort Study.","volume":"23","author":"Andresdottir","year":"2002","journal-title":"Eur Heart J"},{"key":"R36-23-20210210","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/01.CIR.99.9.1165","article-title":"Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland.","volume":"99","author":"Jousilahti","year":"1999","journal-title":"Circulation"},{"key":"R37-23-20210210","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/lt.21222","article-title":"Performance of the new MELD-Na score in predicting 3-month and 1-year mortality in Chinese patients with chronic hepatitis B.","volume":"13","author":"Wong","year":"2007","journal-title":"Liver Transplant"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg201644.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg201644","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg201644.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201605000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:11:42Z","timestamp":1786547502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201605000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2016.44","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}